Max Bayer
@maxonwifi
Followers
3K
Following
9K
Media
454
Statuses
5K
pharma reporter @endpts | past: @FierceBiotech @CBSNews | đź“© [email protected] or maxbayer.10 on Signal | he/him
Brooklyn, NY
Joined July 2010
CM is clearly not computing that if you're willing to pour more money into the program, than pay the buyout. He's talking out out of both sides of his mouth and the fanbase isn't buying it.
Chris McIntosh says bringing Luke Fickell back in 2026 is the right move. Why? Long-winded, vague answers that don't really tell us anything. That's why. https://t.co/csi5sQDMLo (On3+)
0
0
1
"hard things are hard; don't be such a fucking hater" put it on my tombstone
We’ve been heads down @ArcadiaScience for a bit but the @arenabioworks news this week caused me to dump thoughts. hard things are hard; don’t be such a fucking hater. Reflections on parallels w our own institutional experiment here
0
0
3
Another WSJ ed board strike against the FDA was all but guaranteed after the weekend's events. Here it is:
wsj.com
An ethics complaint leads to a resignation, and the agency shifts approval standards.
0
1
7
A man collapsed in the Oval Office yesterday. The internet got the story wrong. My experience struggling to correct the record — including on X — and the warning signs as AI, aggregation, and social media increasingly drive our news consumption. https://t.co/5P8Ueyh25e
30
187
521
At the WH's weight loss drugs press conference, @endpts @maxonwifi asked what the president thinks about Novo buying a small obesity drug developer. Is it anti-competitive? Will the president & FTC help the deal go through? Here's what DJT & Novo's CEO said: $PFE $NVO $MTSR
Trump to the Novo Nordisk CEO: "Maybe you should give us a piece of the company like I've been asking for."
1
6
14
Eli Lilly CEO Dave Ricks told reporters that "retatrutide or eloralintide or any of our future pipeline products, they are not automatically included in this deal." He said that's because the company doesn't yet know the profile of reta and its value.
0
0
3
Makary pushes bounds of FDA commissioner role on prices, drug reviews and personnel -
endpoints.news
The FDA commissioner laid out a more expansive role for the office that would involve him in decisions and details that other top leaders of the agency have historically avoided.
0
2
2
Important clarification from an FDA official: Oral Wegovy is NOT what got a commissioner voucher today, it's a different, higher formulation of semaglutide.
0
3
9
"maybe you should give us a piece of the company like I've been asking"
That was @maxonwifi with the question to Trump about the metsera situation. Trump didn't seem to say much, but Novo CEO made his case at the mics.
1
1
2
That was @maxonwifi with the question to Trump about the metsera situation. Trump didn't seem to say much, but Novo CEO made his case at the mics.
1
2
12
🚨 Breaking: Trump lands sweeping cost cuts on Lilly, Novo weight loss drugs in exchange for Medicare coverage, from @maxonwifi
https://t.co/QkCRZPMjJD
3
4
10
https://t.co/Pc3VSgCFvd Galapagos, which expects have at least ~$3.4B in cash and investments by the end of this year, believes it will be a 35- to 40-person company by the end of 2026.
glpg.com
Strategic review process concluded with intention to wind down cell therapy business, representing optimal capital allocation pathway to support a stronger and sustainable future for...
0
1
1
News: Trump announcement on weight loss drugs is scheduled for 11 a.m. tomorrow, sources tell me. The deal, with Eli Lilly and Novo Nordisk officials, is expected to decrease the drug price to less than $150 a month -- in certain cases.
33
72
314
Fmr. Biden FTC chair Lina Khan on Mamdani's mayoral transition team...
14
40
392
The cover line THE RED APPLE was not very good — look, all apples are red, a red apple is not news to anyone. You have the sense that one came down from on high. But “ON YOUR MARX, GET SET, ZO!” is inspired and I’m glad the Post running with it
3
7
53
There are so many health policy and business reporters that serve as terrific north stars, Dan very much being one of them. I'm lucky to be in a position to report alongside them, and try and be competitive.
Endpoints is a great example of a smaller outlet that’s worked to own an important, complicated lane — biopharma. Helps when you have talented reporters like @maxonwifi @AndrewE_Dunn and editors like @ZacharyBrennan @lydiapflanzer (and of course the inimitable @ArmstrongDrew).
0
1
12
Trump set to announce deal Thursday to lower price of Eli Lilly, Novo Nordisk obesity drugs for some Medicare beneficiaries Part of "most favored nation" pricing push — but viewed inside admin as one of biggest wins given potential public health impact https://t.co/0WAspH8IUv
washingtonpost.com
The GLP-1 drugs, produced by Novo Nordisk and Eli Lilly, have been credited with helping weight-loss, preventing diabetes and other positive effects.
5
9
13